Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Total Liabilities: 2020-2024

Historic Total Liabilities for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to $144.4 million.

  • Prime Medicine's Total Liabilities rose 55.77% to $223.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.2 million, marking a year-over-year increase of 55.77%. This contributed to the annual value of $144.4 million for FY2024, which is 137.51% up from last year.
  • As of FY2024, Prime Medicine's Total Liabilities stood at $144.4 million, which was up 137.51% from $60.8 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Total Liabilities registered a high of $144.4 million during FY2024, and its lowest value of -$2.3 million during FY2020.
  • For the 3-year period, Prime Medicine's Total Liabilities averaged around $83.1 million, with its median value being $60.8 million (2023).
  • In the last 5 years, Prime Medicine's Total Liabilities soared by 2,764.50% in 2021 and then declined by 29.30% in 2022.
  • Prime Medicine's Total Liabilities (Yearly) stood at -$2.3 million in 2020, then skyrocketed by 2,764.50% to $62.3 million in 2021, then declined by 29.30% to $44.0 million in 2022, then spiked by 38.00% to $60.8 million in 2023, then skyrocketed by 137.51% to $144.4 million in 2024.